 |
|
sargramostim plasmid DNA hepatocellular carcinoma vaccine adjuvant
A vaccine adjuvant consisting of a plasmid DNA encoding sargramostim (granulocyte-macrophage colony-stimulating factor). Upon administration, expressed sargramostim may stimulate a cytotoxic T cell response enhancing the host immune response to a concomitantly administered hepatocellular carcinoma vaccine. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonym: | | GM-CSF plasmid DNA hepatocellular carcinoma vaccine adjuvant | | | | Abbreviation: | | phGM-CSF HCC | | |
|
|
